These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37186335)

  • 21. Aggravated Gut Microbiota and Metabolomic Imbalances Are Associated with Hypertension Patients Comorbid with Atrial Fibrillation.
    Fang C; Zuo K; Fu Y; Zhu X; Li J; Zhong J; Xu L; Yang X
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulation of Circulating FGF19 and Bile Acids in Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome.
    Li Z; Liu Y; Yang F; Pang J; Wu Y; Chong Y; Li X
    Biomed Res Int; 2020; 2020():1934541. PubMed ID: 32626734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A gut-brain axis regulating glucose metabolism mediated by bile acids and competitive fibroblast growth factor actions at the hypothalamus.
    Liu S; Marcelin G; Blouet C; Jeong JH; Jo YH; Schwartz GJ; Chua S
    Mol Metab; 2018 Feb; 8():37-50. PubMed ID: 29290621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome.
    Zhao L; Yang W; Chen Y; Huang F; Lu L; Lin C; Huang T; Ning Z; Zhai L; Zhong LL; Lam W; Yang Z; Zhang X; Cheng C; Han L; Qiu Q; Shang X; Huang R; Xiao H; Ren Z; Chen D; Sun S; El-Nezami H; Cai Z; Lu A; Fang X; Jia W; Bian Z
    J Clin Invest; 2020 Jan; 130(1):438-450. PubMed ID: 31815740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Farnesoid X receptor-dependent and -independent pathways mediate the transcriptional control of human fibroblast growth factor 19 by vitamin A.
    Jahn D; Sutor D; Dorbath D; Weiß J; Götze O; Schmitt J; Hermanns HM; Geier A
    Biochim Biophys Acta; 2016 Feb; 1859(2):381-92. PubMed ID: 26723851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19.
    Piglionica M; Cariello M; Moschetta A
    Curr Opin Pharmacol; 2018 Dec; 43():93-98. PubMed ID: 30223181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
    Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
    Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
    Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
    Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.
    Zweers SJ; de Vries EM; Lenicek M; Tolenaars D; de Waart DR; Koelfat KV; Groen AK; Olde Damink SW; Beuers U; Ponsioen C; Jansen PL; Schaap FG
    Hepatol Int; 2017 Jan; 11(1):132-140. PubMed ID: 27696157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics of Bile Acid Profiles, GLP-1, and FGF19 After Laparoscopic Gastric Banding.
    Thöni V; Pfister A; Melmer A; Enrich B; Salzmann K; Kaser S; Lamina C; Ebenbichler CF; Hackl H; Tilg H; Moschen AR
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2974-2984. PubMed ID: 28591793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
    Friedrich D; Marschall HU; Lammert F
    BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.
    Kakiyama G; Pandak WM; Gillevet PM; Hylemon PB; Heuman DM; Daita K; Takei H; Muto A; Nittono H; Ridlon JM; White MB; Noble NA; Monteith P; Fuchs M; Thacker LR; Sikaroodi M; Bajaj JS
    J Hepatol; 2013 May; 58(5):949-55. PubMed ID: 23333527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose.
    Zhang J; Li H; Zhou H; Fang L; Xu J; Yan H; Chen S; Song Q; Zhang Y; Xu A; Fang Q; Ye Y; Jia W
    Sci Rep; 2017 Jul; 7(1):6042. PubMed ID: 28729691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chenodeoxycholic acid on the secretion of gut peptides and fibroblast growth factors in healthy humans.
    Meyer-Gerspach AC; Steinert RE; Keller S; Malarski A; Schulte FH; Beglinger C
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3351-8. PubMed ID: 23783097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of bile acid profile by gut microbiota in chronic hepatitis B.
    Wang X; Chen L; Wang H; Cai W; Xie Q
    J Cell Mol Med; 2020 Feb; 24(4):2573-2581. PubMed ID: 31925905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Divergent effects of resistance and endurance exercise on plasma bile acids, FGF19, and FGF21 in humans.
    Morville T; Sahl RE; Trammell SA; Svenningsen JS; Gillum MP; Helge JW; Clemmensen C
    JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
    Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
    JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease.
    Wunsch E; Milkiewicz M; Wasik U; Trottier J; Kempińska-Podhorodecka A; Elias E; Barbier O; Milkiewicz P
    Sci Rep; 2015 Aug; 5():13462. PubMed ID: 26293907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAGln, an Atrial Fibrillation-Linked Gut Microbial Metabolite, Acts as a Promoter of Atrial Myocyte Injury.
    Fang C; Zuo K; Jiao K; Zhu X; Fu Y; Zhong J; Xu L; Yang X
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease.
    Adams LA; Wang Z; Liddle C; Melton PE; Ariff A; Chandraratna H; Tan J; Ching H; Coulter S; de Boer B; Christophersen CT; O'Sullivan TA; Morrison M; Jeffrey GP
    Liver Int; 2020 Jun; 40(6):1356-1365. PubMed ID: 32243703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.